S5YA Stock Overview
Engages in the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies primarily in Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 6/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Sigma Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$1.69 |
| 52 Week High | AU$1.69 |
| 52 Week Low | AU$0.41 |
| Beta | 0.15 |
| 11 Month Change | 52.25% |
| 3 Month Change | 131.51% |
| 1 Year Change | 316.26% |
| 33 Year Change | 459.60% |
| 5 Year Change | 324.62% |
| Change since IPO | 168.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| S5YA | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 20.7% | 0.2% | 0.8% |
| 1Y | 316.3% | 13.9% | 8.6% |
Return vs Industry: S5YA exceeded the German Healthcare industry which returned 17.4% over the past year.
Return vs Market: S5YA exceeded the German Market which returned 9.1% over the past year.
Price Volatility
| S5YA volatility | |
|---|---|
| S5YA Average Weekly Movement | 12.8% |
| Healthcare Industry Average Movement | 4.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: S5YA's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: S5YA's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1912 | n/a | Vikesh Ramsunder | www.sigmahealthcare.com.au |
Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies primarily in Australia. The company operates various aligned pharmacies, including branded pharmacies under the Amcal, Discount Drug Stores, Guardian, and PharmaSave brands. It also provides retail support services to its branded network of pharmacy members; dose administration aid services; and third and fourth-party logistics services to pharmaceutical manufacturers and other supplier partners.
Sigma Healthcare Limited Fundamentals Summary
| S5YA fundamental statistics | |
|---|---|
| Market cap | €2.60b |
| Earnings (TTM) | -€1.85m |
| Revenue (TTM) | €2.15b |
1.2x
P/S Ratio-1,402x
P/E RatioIs S5YA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| S5YA income statement (TTM) | |
|---|---|
| Revenue | AU$3.48b |
| Cost of Revenue | AU$3.25b |
| Gross Profit | AU$227.81m |
| Other Expenses | AU$230.81m |
| Earnings | -AU$3.00m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0019 |
| Gross Margin | 6.55% |
| Net Profit Margin | -0.086% |
| Debt/Equity Ratio | 0% |
How did S5YA perform over the long term?
See historical performance and comparison